Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

被引：90

作者：

Ruiz, Agustin ^{[1
,2
]}

Dols-Icardo, Oriol ^{[3
,4
]}

Bullido, Maria J. ^{[4
,5
,6
]}

Pastor, Pau ^{[4
,7
,8
]}

Rodriguez-Rodriguez, Eloy ^{[4
,9
,10
]}

Lopez de Munain, Adolfo ^{[4
,11
,12
]}

de Pancorbo, Marian M. ^{[13
]}

Perez-Tur, Jordi ^{[4
,14
]}

Alvarez, Victoria ^{[15
]}

Antonell, Anna ^{[16
]}

Lopez-Arrieta, Jesus ^{[6
,17
]}

Hernandez, Isabel ^{[1
,2
]}

Tarraga, Lluis ^{[1
,2
]}

Boada, Merce ^{[1
,2
,18
]}

Lleo, Alberto ^{[3
,4
]}

Blesa, Rafael ^{[3
,4
]}

Frank-Garcia, Ana ^{[4
,6
,19
]}

Sastre, Isabel ^{[4
,5
,6
]}

Razquin, Cristina ^{[4
,7
]}

Ortega-Cubero, Sara ^{[4
,7
,8
]}

Lorenzo, Elena ^{[4
,7
]}

Sanchez-Juan, Pascual ^{[4
,9
,10
]}

Combarros, Onofre ^{[4
,9
,10
]}

Moreno, Fermin ^{[4
,11
,12
]}

Gorostidi, Ana ^{[4
,11
,12
]}

Elcoroaristizabal, Xabier ^{[13
]}

Baquero, Miquel ^{[20
,21
]}

Coto, Eliecer ^{[15
]}

Sanchez-Valle, Raquel ^{[16
]}

Clarimon, Jordi ^{[3
,4
]}

机构：

[1] Inst Catala Neurociencies Aplicades, Fundacio ACE, Alzheimer Res Ctr, Barcelona, Spain

[2] Inst Catala Neurociencies Aplicades, Fundacio ACE, Memory Clin, Barcelona, Spain

[3] Univ Autonoma Barcelona, Hosp Sant Pau, Sant Pau Biomed Res Inst, Memory Unit,Dept Neurol, E-08193 Barcelona, Spain

[4] Ctr Networked Biomed Res Neurodegenerat Dis, CIBERNED, Madrid, Spain

[5] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain

[6] Hosp la Paz IdIPaz, Inst Sanit Res, Madrid, Spain

[7] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neurogenet Lab, E-31080 Pamplona, Spain

[8] Univ Navarra, Sch Med, Clin Univ Navarra, Dept Neurol, E-31080 Pamplona, Spain

[9] Univ Cantabria, Univ Hosp Marques de Valdecilla, Neurol Serv, E-39005 Santander, Spain

[10] IFIMAV, Univ Hosp Marques de Valdecilla, Neurol Serv, Santander, Spain

[11] Univ Basque Contry EHU UPV, Inst Biodonostia, Neurosci Area, San Sebastian, Spain

[12] Univ Basque Contry EHU UPV, Dept Neurosci, San Sebastian, Spain

[13] Univ Pais Vasco UPV EHU, Ctr Invest Lascaray Ikergunea, BIOMICs Res Grp, Vitoria, Spain

[14] CSIC, Inst Biomed Valenciae, Valencia, Spain

[15] Hosp Univ Cent Asturias, Mol Genet Lab, Genet Unit, Oviedo, Spain

[16] IDIBAPS, Hosp Clin, Dept Neurol, Barcelona, Spain

[17] Univ Hosp La Paz Cantoblanco, Memory Unit, Madrid, Spain

[18] Univ Autonoma Barcelona VHIR UAB, Inst Recerca, Hosp Univ Vall dHebron, Barcelona, Spain

[19] Hosp Univ La Paz UAM, Neurol Serv, Madrid, Spain

[20] Hosp Univ La Fe, Neurol Serv, Valencia, Spain

[21] Politecn La Fe, Valencia, Spain

来源：

NEUROBIOLOGY OF AGING | 2014年 / 35卷 / 02期

关键词：

Alzheimer's disease; Frontotemporal dementia; TREM2; Genetic association; p.R47H; Rare variant; MUTATIONS;

D O I：

10.1016/j.neurobiolaging.2013.08.011

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

A non-synonymous genetic rare variant, rs75932628-T (p.R47H), in the TREM2 gene has recently been reported to be a strong genetic risk factor for Alzheimer's disease (AD). Also, rare recessive mutations have been associated with frontotemporal dementia (FTD). We aimed to investigate the role of p.R47H variant in AD and FTD through a multi-center study comprising 3172 AD and 682 FTD patients and 2169 healthy controls from Spain. We found that 0.6% of AD patients carried this variant compared to 0.1% of controls (odds ratio [OR] = 4.12, 95% confidence interval [CI] = 1.21-14.00, p = 0.014). A meta-analysis comprising 32,598 subjects from 4 previous studies demonstrated the large effect of the p.R47H variant in AD risk (OR = 4.11, 95% CI = 2.99-5.68, p = 5.27 x 10(-18)). We did not find an association between p.R47H and age of onset of AD or family history of dementia. Finally, none of the FTD patients harbored this genetic variant. These data strongly support the important role of p.R47H in AD risk, and suggest that this rare genetic variant is not related to FTD. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：444.e1 / 444.e4

页数：4

共 50 条

[31] Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant
Martins, Soraia
Yigit, Hatice
Bohndorf, Martina
Graffmann, Nina
Fiszl, Aurelian Robert
Wruck, Wasco
Sleegers, Kristel
Van Broeckhoven, Christine
Adjaye, James
STEM CELL RESEARCH, 2018, 30 : 141 - 144
[32] Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant
Schroeter, Friederike
Sleegers, Kristel
Cuyvers, Elise
Bohndorf, Martina
Wruck, Wasco
Van Broeckhoven, Christine
Adjaye, James
STEM CELL RESEARCH, 2016, 16 (01) : 113 - 115
[33] Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of TREM2
Ogonowski, Natalia
Santamaria-Garcia, Hernando
Baez, Sandra
Lopez, Andrea
Laserna, Andres
Garcia-Cifuentes, Elkin
Ayala-Ramirez, Paola
Zarante, Ignacio
Suarez-Obando, Fernando
Reyes, Pablo
Kauffman, Marcelo
Cochran, Nick
Schulte, Michael
Sirkis, Daniel W.
Spina, Salvatore
Yokoyama, Jennifer S.
Miller, Bruce L.
Kosik, Kenneth S.
Matallana, Diana
Ibanez, Agustin
JOURNAL OF MEDICAL GENETICS, 2023, 60 (09) : 894 - 904
[34] Lymphoblast-derived integration-free iPSC line AD-TREM2-1 from a 67 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant
Martins, Soraia
Yigit, Hatice
Bohndorf, Martina
Graffmann, Nina
Fiszl, Aurelian Robert
Wruck, Wasco
Sleegers, Kristel
Van Broeckhoven, Christine
Adjaye, James
STEM CELL RESEARCH, 2018, 29 : 60 - 63
[35] Evidence of Trem2 Variant Associated with Triple Risk of Alzheimer's Disease
Abduljaleel, Zainularifeen
Al-Allaf, Faisal A.
Khan, Wajahatullah
Athar, Mohammad
Shahzad, Naiyer
Taher, Mohiuddin M.
Elrobh, Mohamed
Alanazi, Mohammed S.
El-Huneidi, Waseem
PLOS ONE, 2014, 9 (03):
[36] Trem2 Splicing and Expression are Preserved in a Human Aß-producing, Rat Knock-in Model of Trem2-R47H Alzheimer's Risk Variant
Tambini, Marc D.
D'Adamio, Luciano
SCIENTIFIC REPORTS, 2020, 10 (01)
[37] Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer’s Risk Variant
Marc D. Tambini
Luciano D’Adamio
Scientific Reports, 10
[38] TREM2 VARIANTS INCREASE RISK OF TYPICAL EARLY-ONSET ALZHEIMER'S DISEASE BUT NOT OF PRION OR FRONTOTEMPORAL DEMENTIA
Slattery, C. F.
Beck, J.
Harper, L.
Adamson, G.
Abdi, Z.
Uphill, J.
Campbell, T.
Druyeh, R.
Mahoney, C. J.
Rohrer, J. D.
Kenny, J.
Lowe, J.
Leung, K. K.
Barnes, J.
Clegg, S. L.
Blair, M.
Nicholas, J. M.
Guerreiro, R. J.
Rowe, J. B.
Ponto, C.
Zerr, I.
Kretzschmar, H.
Gambetti, P.
Crutch, S. J.
Warren, J. D.
Rossor, M. N.
Fox, N. C.
Collinge, J.
Schott, J. M.
Mead, S.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (08):
[39] Elucidating the Role of TREM2 in Alzheimer's Disease
Ulrich, Jason D.
Ulland, Tyler K.
Colonna, Marco
Holtzman, David M.
NEURON, 2017, 94 (02) : 237 - 248
[40] TREM2 MUTATIONS: RISK FACTOR FOR ALZHEIMER'S DISEASE AND NEW GENETIC CAUSE FOR FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION
Gurvit, Hakan
NEUROBIOLOGY OF AGING, 2014, 35 (03) : 718 - 718

← 1 2 3 4 5 →